Cochlear is forecast to grow earnings and revenue by 8.1% and 4.5% per annum respectively. EPS is expected to grow by 7.8% per annum. Return on equity is forecast to be 19% in 3 years.
Key information
8.1%
Earnings growth rate
7.75%
EPS growth rate
Medical Equipment earnings growth
0%
Revenue growth rate
4.5%
Future return on equity
19.02%
Analyst coverage
Good
Last updated
18 May 2026
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
BMV:COH N - Analysts future estimates and past financials data (AUD Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
6/30/2028
2,591
379
370
480
14
6/30/2027
2,420
327
322
434
15
6/30/2026
2,326
252
250
371
15
12/31/2025
2,339
345
166
265
N/A
9/30/2025
2,341
367
150
251
N/A
6/30/2025
2,343
389
135
238
N/A
3/31/2025
2,326
380
193
290
N/A
12/31/2024
2,309
371
251
342
N/A
9/30/2024
2,272
364
275
365
N/A
6/30/2024
2,236
357
299
389
N/A
3/31/2024
2,193
354
317
410
N/A
12/31/2023
2,149
350
335
430
N/A
9/30/2023
2,043
326
301
396
N/A
6/30/2023
1,936
301
267
362
N/A
3/31/2023
1,824
281
263
352
N/A
12/31/2022
1,713
261
259
341
N/A
9/30/2022
1,681
275
279
359
N/A
6/30/2022
1,648
289
299
377
N/A
3/31/2022
1,612
273
266
340
N/A
12/31/2021
1,575
257
233
304
N/A
9/30/2021
1,536
291
216
285
N/A
6/30/2021
1,498
324
199
265
N/A
3/31/2021
1,403
82
-52
34
N/A
12/31/2020
1,308
-160
-302
-198
N/A
9/30/2020
1,314
-199
-295
-178
N/A
6/30/2020
1,321
-238
-288
-158
N/A
3/31/2020
1,400
34
-80
50
N/A
12/31/2019
1,479
306
128
259
N/A
9/30/2019
1,453
291
N/A
277
N/A
6/30/2019
1,427
277
N/A
296
N/A
3/31/2019
1,422
270
N/A
313
N/A
12/31/2018
1,418
264
N/A
330
N/A
9/30/2018
1,391
255
N/A
294
N/A
6/30/2018
1,364
246
N/A
258
N/A
3/31/2018
1,329
234
N/A
254
N/A
12/31/2017
1,294
223
N/A
250
N/A
9/30/2017
1,274
223
N/A
255
N/A
6/30/2017
1,254
224
N/A
260
N/A
3/31/2017
1,218
215
N/A
237
N/A
12/31/2016
1,182
206
N/A
214
N/A
9/30/2016
1,156
198
N/A
199
N/A
6/30/2016
1,131
189
N/A
185
N/A
3/31/2016
1,088
179
N/A
179
N/A
12/31/2015
1,045
168
N/A
172
N/A
9/30/2015
986
157
N/A
181
N/A
6/30/2015
926
146
N/A
189
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: COH N's forecast earnings growth (8.1% per year) is below the savings rate (9%).
Earnings vs Market: COH N's earnings (8.1% per year) are forecast to grow slower than the MX market (9.1% per year).
High Growth Earnings: COH N's earnings are forecast to grow, but not significantly.
Revenue vs Market: COH N's revenue (4.5% per year) is forecast to grow slower than the MX market (6.2% per year).
High Growth Revenue: COH N's revenue (4.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: COH N's Return on Equity is forecast to be low in 3 years time (19%).
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/22 16:51
End of Day Share Price
2026/02/27 00:00
Earnings
2025/12/31
Annual Earnings
2025/06/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cochlear Limited is covered by 26 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.